close to approving two different drug regimens for treating ulcers caused by Helicobacter pylori
The FDA is close to approving two different drug regimens for treating ulcers caused by Helicobacter pylori.
These will be the first drugs to get approved for this indication. This means that companies will finally be able to promote them for this use.
One regimen is dual therapy with Biaxin (clarithromycin) and Prilosec (omeprazole). (Biaxin 500 mg TID and Prilosec 40 mg/day for 2 weeks...followed by 2 more weeks of Prilosec 20 mg/day.)
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote